Pulmonary hypertension

These companies develop drugs that treat high blood pressure in the arteries of the lungs.
+7.9%
over 3 months · S&P 500 −2.1%

Key indicators

Health
53 / 100
Fragile
Solid
Price
P/E 36
Cheap
Expensive
Up over 1 year
5 of 8
Volatility
67%
Calm
Choppy
Health and price: against the other tags.